BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 249 filers reported holding BLUEBIRD BIO INC in Q3 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $74,231 | -44.2% | 23,343 | +11.5% | 0.02% | -53.8% |
| Q3 2022 | $133,000 | -57.8% | 20,940 | +112.7% | 0.05% | -81.9% |
| Q2 2021 | $315,000 | -31.8% | 9,846 | +87.0% | 0.29% | -22.8% |
| Q4 2019 | $462,000 | +97.4% | 5,265 | +106.9% | 0.37% | +74.6% |
| Q3 2019 | $234,000 | -74.2% | 2,545 | -56.0% | 0.21% | -26.0% |
| Q2 2018 | $908,000 | +50.3% | 5,783 | +31.4% | 0.29% | +68.4% |
| Q3 2017 | $604,000 | -33.1% | 4,400 | -48.8% | 0.17% | -45.2% |
| Q2 2017 | $903,000 | +150.1% | 8,600 | +1.2% | 0.31% | +29.5% |
| Q1 2016 | $361,000 | – | 8,500 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |